Skip to search formSkip to main contentSkip to account menu

CV 3317

Known as: CV-3317 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

delapril

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Effect of delapril hydrochloride on angiotensin II release from isolated rat hind legs.
1989
1989
Antihypertensive and hormonal effects of the new oral angiotensin-converting enzyme inhibitor delapril (CV-3317) in essential hypertension
Delapril est administre a dose unique ou a doses repetees et on teste son action antihypertensive et ses effets sur les systemes… 
1988
1988
Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjects
Pharmacokinetic properties of a new angiotensin‐converting enzyme inhibitor, delapril (CV‐3317), which converts to two active… 
1987
1987
Delapril Hydrochloride (CV-3317) のウサギにおける器官形成期投与試験
1986
1986
Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.
The antihypertensive action of N-[N-[(S)-1-ethoxycarbonyl-3-phenyl-propyl]-L-alanyl]-N-(indan-2-yl) glycine hydrochloride (CV… 
1986
1986
Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor.
A new angiotensin converting enzyme (ACE) inhibitor, N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2-yl)glycine… 
1985
1985
Determination of a new angiotensin converting enzyme inhibitor (CV-3317) and its metabolites in serum and urine by high-performance liquid chromatography.
1984
1984
Effects of a new angiotensin converting enzyme inhibitor, N-〔N-{(S)-1-ethoxycarbonyl-3-phenyl-propyl}-L-alanyl〕-N-(indan-2-yl) glycine hydrochloride (CV-3317) in normal men
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)